Pharmaceuticals News and Research

RSS

Multi-million dollar cooperative agreement for SMA drug development program

Paratek Pharmaceuticals (Boston, MA) and Families of Spinal Muscular Atrophy (Elk Grove Village, IL) announced today that a jointly funded drug development program for Spinal Muscular Atrophy (SMA) has been awarded a multi-million dollar cooperative agreement from the National Institute of Neurological Disorders and Stroke (NINDS).

19 Oct 2009

HealthScape Consumer to analyze patient and consumer data

Healthy Advice Networks, the nation's leading provider of physician office-based patient-education programs, announces a groundbreaking measurement program to track consumer purchase behavior, not just purchase intent, for OTC and consumer health brands.

19 Oct 2009

Access Pharmaceuticals' update on its European commercial launch of Mugard

ACCESS PHARMACEUTICALS, INC. today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy.

15 Oct 2009

Overview of innovative technology for treating ischemic and autoimmune disorders

Pluristem Therapeutics Inc. today announced that it will present at the New England-Israel Life Sciences Summit at the Brandeis International Business School in Waltham, Mass. Zami Aberman, chairman and CEO of Pluristem will present an update on the company and an overview of its technology at 9:40 EDT, Oct 27, 2009.

15 Oct 2009

Mylan Pharmaceuticals receives approval for Topiramate Capsules

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Capsules (Sprinkle), 15 mg and 25 mg.

15 Oct 2009

AcelRx Pharmaceuticals’ programs to feature at upcoming annual meeting

AcelRx Pharmaceuticals, Inc. announced today that results of its Phase 1 studies evaluating the pharmacokinetics of its oral transmucosal NanoTab(TM) formulation of sufentanil will be featured in two oral presentations at the upcoming American Society of Anesthesiologists Annual Meeting in New Orleans.

15 Oct 2009

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).

15 Oct 2009

Prometheus Laboratories introduces three new cancer diagnostic products

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the nationwide commercial launch of three new cancer diagnostic products: ProOnc TumorSource Dx, ProOnc Squamous Dx and ProOnc Mesothelioma Dx. Each of these tests is based on recently developed, highly sensitive microRNA technology.

15 Oct 2009

Inspire to present its denufosol tetrasodium cystic fibrosis program data at the 23rd NACFC

Inspire Pharmaceuticals, Inc. announced today Inspire scientists and collaborators will present data from the denufosol tetrasodium cystic fibrosis (CF) program in a poster presentation at the 23rd Annual North American Cystic Fibrosis Conference (NACFC) October 15 - 17, 2009 in Minneapolis, MN.

15 Oct 2009

Northern Light partners with EBSCO Publishing to provide bio-pharma and health sciences news

Northern Light (www.northernlight.com) today announced a partnership with EBSCO Publishing (EBSCO) (www.ebscohost.com) that will let mutual customers directly search and access more than 4,000 bio-pharmaceutical, health sciences and general business magazines, journals and other news sources through Northern Light SinglePoint(TM) strategic research portals.

15 Oct 2009

IMS Health introduces IMS MIDAS Global Biologics

IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS MIDAS Global Biologics™, a powerful offering that enables the company’s clients to make more confident decisions as they assess opportunities in the fast-growing, $120 billion worldwide biologics market.

15 Oct 2009

Meda Pharmaceuticals recognized with the "Solutions Superstar" award by EmployersWeb

SEI today announced that one of the company's institutional clients -- Meda Pharmaceuticals -- was recognized with the "Solutions Superstar" award by EmployersWeb. The award honors Meda for their outstanding and innovative defined benefit plan management including asset allocation changes and strategies aimed at matching the duration of invested assets with the plan's liabilities.

15 Oct 2009

ADI and CeTeCancer collaborate for research project

Radient Pharmaceuticals Corporation, a US-based pharmaceutical company, announced today it has entered into a collaboration agreement through its wholly owned subsidiary AMDL Diagnostics, Inc. (ADI) with CeTeCancer -- a Chilean-based research laboratory -- to validate the effectiveness of Radient Pharmaceuticals' Onko-Sure™ in vitro diagnostic (IVD) cancer test as an early detection and prevention test for lung cancer.

15 Oct 2009

Pharma IQ reports on the 7th Annual Cold Chain Distribution for Pharmaceuticals conference

Pharma IQ, a division of IQPC, held the 7th Annual Cold Chain Distribution for Pharmaceuticals, September 21-24, 2009 at the Pennsylvania Convention Center in Philadelphia, PA. This industry-leading global forum gathered more than 350 pharmaceutical, regulatory and logistic experts to address the greatest challenges supply chain professionals face today.

From IQPC Ltd 15 Oct 2009

BNA Books publishes the 2009 Cumulative Supplement to Pharmaceutical Patent Law

The 2009 Cumulative Supplement to Pharmaceutical Patent Law delivers the latest legal developments in pharmaceutical patent law.

15 Oct 2009

Lower profitability linked to insufficient sales training, reveals survey

When it comes to slumping profitability in the current pharmaceutical sales industry, it is easy to point a finger at a shrinking sales force, the economic downturn and strict government regulations. But new data from the 2009 Leadership Skills Survey, conducted by pharmaceutical consulting firm DELTA POINT, Inc. (http://www.gottochange.com), indicates that the root of the problem actually rests with the productivity of sales associates.

15 Oct 2009

Linguamatics launches I2E 3.1 text mining platform for pharmaceutical companies

Linguamatics, a leader in enterprise text mining for the life science and other markets, today announced the availability of I2E 3.1 for unlocking value from the wealth of unstructured text resources available to pharmaceutical companies. I2E is a high performance natural language processing (NLP)-based text mining platform that streamlines knowledge discovery from text.

15 Oct 2009

Boehringer Ingelheim implements the iStudyReporter Bioanalytics reporting solution

Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world’s 20 leading pharmaceutical companies. Boehringer Ingelheim’s business areas include Prescription Medicines, Consumer Health Care and Biopharmaceuticals, as well as Pharma Chemicals and Animal Health.

15 Oct 2009

First Priority implements Global Vision's automated inspection solutions

During tough economic times, First Priority, manufacturer of generic veterinary pharmaceutical products, implemented Global Vision's automated inspection solutions in an effort to reduce costs without compromising efficiencies and quality of their products.

15 Oct 2009

Medifacts International bags $2.7 million contract with a top ten pharmaceutical company

MEDIFACTS INTERNATIONAL, INC., one of the largest global providers of noninvasive cardiac diagnostic services, today announced the award of a $2.7 million contract with a top ten pharmaceutical company to provide comprehensive cardiac safety and efficacy services for a large late stage clinical trial.

15 Oct 2009

Pharmaceuticals News and Research

Multi-million dollar cooperative agreement for SMA drug development program

HealthScape Consumer to analyze patient and consumer data

Access Pharmaceuticals' update on its European commercial launch of Mugard

Overview of innovative technology for treating ischemic and autoimmune disorders

Mylan Pharmaceuticals receives approval for Topiramate Capsules

AcelRx Pharmaceuticals’ programs to feature at upcoming annual meeting

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

Prometheus Laboratories introduces three new cancer diagnostic products

Inspire to present its denufosol tetrasodium cystic fibrosis program data at the 23rd NACFC

Northern Light partners with EBSCO Publishing to provide bio-pharma and health sciences news

IMS Health introduces IMS MIDAS Global Biologics

Meda Pharmaceuticals recognized with the "Solutions Superstar" award by EmployersWeb

ADI and CeTeCancer collaborate for research project

Pharma IQ reports on the 7th Annual Cold Chain Distribution for Pharmaceuticals conference

BNA Books publishes the 2009 Cumulative Supplement to Pharmaceutical Patent Law

Lower profitability linked to insufficient sales training, reveals survey

Linguamatics launches I2E 3.1 text mining platform for pharmaceutical companies

Boehringer Ingelheim implements the iStudyReporter Bioanalytics reporting solution

First Priority implements Global Vision's automated inspection solutions

Medifacts International bags $2.7 million contract with a top ten pharmaceutical company

Event guide: 3rd EHS for Biopharma Summit eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring